ArticleMMWR. Morbidity and mortality weekly report2022

Characteristics and Adverse Events of Patients for Whom Nifurtimox Was Released Through CDC-Sponsored Investigational New Drug Program for Treatment of Chagas Disease - United States, 2001-2021.

Andrew Abbott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.